Schedule 13G ownership disclosure

Lakefront Biotherapeutics NV

Security class unavailable · CUSIP: B44170106

Event date: 2021-01-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,091,219
Percent of class
10.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001562230-21-000004
Form type
SC 13G/A
Filer
Capital International Investors
CIK
CIK 1562230
Filed
Feb 10, 2021
Reporting period
Jan 29, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub